首页> 外国专利> USE OF BETA-HYDROXY BETA-METHYLBUTYRATE IN COMBINATION WITH LEUCIC ACID FOR ALLEVIATING STATIN SIDE EFFECTS

USE OF BETA-HYDROXY BETA-METHYLBUTYRATE IN COMBINATION WITH LEUCIC ACID FOR ALLEVIATING STATIN SIDE EFFECTS

机译:β-羟基β-甲基丁酸羟基酯与白酸结合使用可缓解他汀类药物的副作用

摘要

Disclosed herein are methods and compositions for alleviating side effects of statin administration, such as myopathic or myalgic side effects, short-term memory loss, abnormal liver function, glucose intolerance, hyperglycemia, increased risk for diabetes, or cumulative trauma disorder, comprising administration of ß-hydroxy ß-methylbutyrate (HMB) and leucic acid to an individual taking a statin. Also disclosed are methods and compositions for alleviating acute rhabdomyolysis, and methods and compositions for treating cumulative trauma disorder, comprising administration of HMB and leucic acid. The disclosure further provides uses of HMB and leucic acid in combination with a statin to alleviate side effects of statin administration, treat statin intolerance, treat cumulative trauma disorder, and treat acute rhabdomyolysis.
机译:本文公开了减轻他汀类药物施用的副作用的方法和组合物,所述副作用例如肌病或肌痛性副作用,短期记忆丧失,肝功能异常,葡萄糖耐量,高血糖症,糖尿病风险增加或累积性创伤疾病,包括施用他汀类药物。服用他汀类药物的人的ß-羟基ß-甲基丁酸(HMB)和白酸。还公开了减轻急性横纹肌溶解的方法和组合物,以及治疗累积性创伤疾病的方法和组合物,包括施用HMB和白氨酸。本公开进一步提供了HMB和白血酸与他汀类药物联合使用以减轻他汀类药物施用的副作用,治疗他汀类药物不耐受,治疗累积性创伤疾病和治疗急性横纹肌溶解的用途。

著录项

  • 公开/公告号CA3030740A1

    专利类型

  • 公开/公告日2018-01-25

    原文格式PDF

  • 申请/专利权人 WINTERFIELD ROLAND W.;

    申请/专利号CA20173030740

  • 发明设计人 WINTERFIELD ROLAND W.;

    申请日2017-07-19

  • 分类号A61K31/19;A61K31/198;A61K31/22;A61K31/366;A61K31/40;A61K31/404;A61K31/47;A61K31/505;A61P21;A61P43;

  • 国家 CA

  • 入库时间 2022-08-21 12:47:41

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号